聚糖在疾病调节中的进步:编程细胞死亡的多方面调节
Lianxiang Luo1, Fuhai Feng2, Ai Zhong2
1The Marine Biomedical Research Institute of Guangdong Zhanjiang, School of Ocean and Tropical Medicine. Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
多糖,天然化合物,显示出调节细胞死亡途径的潜力,用于疾病治疗. 本综述探讨了它们的机制和与人类疾病的联系,有助于未来的临床应用.
科学领域:
- 生物化学和分子生物学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 编程细胞死亡 (PCD) 或调控细胞死亡 (RCD) 在生理学和疾病中至关重要.
- 像TP53,KRAS和NOTCH这样的信号通路调节RCD.
- 多糖是具有多种药理作用的天然产品.
研究的目的:
- 审查多糖如何发挥治疗作用.
- 探索RCD和人类疾病之间的联系.
- 为了为多糖生物活性的临床应用提供基础.
主要方法:
- 关于 RCD 机制的文献综述.
- 在RCD中涉及的信号通路的分析.
- 检查多糖的生物活性和治疗潜力.
主要成果:
- 多糖体表现出针对信号传导通路的生物活动.
- 不同类型的RCD与各种人类疾病有关.
- 多糖体在调节RCD以获得治疗益处方面显示出潜力.
结论:
- 多糖为涉及RCD的疾病提供了一个有希望的治疗途径.
- 了解多糖机制可以推进RCD向治疗.
- 进一步的研究可以支持多糖的临床使用.
更多相关视频
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
相关概念视频
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
iPS Cell Differentiation
Protein Glycosylation
Glycosylation occurs in...
Apoptosis
EPS and iPS Cells in Disease Research
